PREVENT supports the preclinical development of innovative cancer prevention interventions and biomarkers towards clinical applications. PREVENT provides NCI contract resources and expertise to generate data and/or materials needed for agent development instead of direct funding. The program is focused on unmet research needs that are not adequately addressed by the private sector. PREVENT’s current research priority areas include immunoprevention, chemoprevention, and clinically translatable biomarkers.
Read more About PREVENT.
Submission deadlines occur twice per year on the first Monday in February and September.
NEXT Deadline: February 3, 2020
Instructions for Applying
The application template was updated on 09/12/2017.
95 Projects from PREVENT Cycles 1 through 16:
- 59 chemoprevention projects
- 28 immunoprevention projects
- 8 biomarker projects
PREVENT and Consortia Project Results Presented at the AACR Annual Meeting 2019
NCI participated in the American Association for Cancer Research (AACR) Annual Meeting held March 29 - April 3, 2019 at Georgia World Congress Center in Atlanta, GA, including the presentation of research results from the latest PREVENT- and Consortia-supported projects.